Abstract
The influence of dopamine receptor agonists in the transdermal and oral forms of drugs and amantadine for a non-motor autonomic fluctuations of patients with different duration of the disease during the treatment of Parkinson's in a stable dose of levodopa were established. It was analysed, that the use of dopamine receptor agonists in the transdermal and oral forms of drugs reduce the frequency and duration of vegetative non-motor fluctuations of patients with Parkinson's disease. The use of amantadine sulphate has little effect in a decrease of non-motor autonomic fluctuations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
